{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:36:45Z","timestamp":1775493405825,"version":"3.50.1"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Dengue virus (DENV) is responsible for approximately 100 million cases of dengue fever annually, including severe forms such as hemorrhagic dengue and dengue shock syndrome. Despite intensive vaccine research and development spanning several decades, a universally accepted and approved vaccine against dengue fever has not yet been developed. The major challenge associated with the development of such a vaccine is that it should induce simultaneous and equal protection against the four DENV serotypes, because past infection with one serotype may greatly increase the severity of secondary infection with a distinct serotype, a phenomenon known as antibody-dependent enhancement (ADE). Using a lentiviral vector platform that is particularly suitable for the induction of cellular immune responses, we designed a tetravalent T-cell vaccine candidate against DENV (\u201cLV-DEN\u201d). This vaccine candidate has a strong CD8<jats:sup>+<\/jats:sup> T-cell immunogenicity against the targeted non-structural DENV proteins, without inducing antibody response against surface antigens. Evaluation of its protective potential in the preclinical flavivirus infection model, i.e., mice knockout for the receptor to the type I IFN, demonstrated its significant protective effect against four distinct DENV serotypes, based on reduced weight loss, viremia, and viral loads in peripheral organs of the challenged mice. These results provide proof of concept for the use of lentiviral vectors for the development of efficient polyvalent T-cell vaccine candidates against all DENV serotypes.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1208041","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:34:38Z","timestamp":1692246878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses"],"prefix":"10.3389","volume":"14","author":[{"given":"Kirill","family":"Nemirov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Authi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Souque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Moncoq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Noirat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline","family":"Bourgine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laleh","family":"Majlessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Charneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.07.001","article-title":"Progress and works in progress: Update on flavivirus vaccine development","volume":"39","author":"Collins","year":"2017","journal-title":"Clin Ther"},{"key":"B2","first-page":"895","article-title":"Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.081","article-title":"Second Five-Year Follow-up after a Booster Vaccination against Tick-Borne Encephalitis Following Different Primary Vaccination Schedules Demonstrates at Least 10\u202fYears Antibody Persistence","volume":"37","author":"Beran","year":"2019","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw533","article-title":"Persistence of wild-type Japanese encephalitis virus strains cross-neutralization 5 years after JE-CV immunization","volume":"215","author":"Feroldi","year":"2017","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune Response to Dengue and Zika","volume":"36","author":"Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections","volume":"19","author":"St. John","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"Screaton","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.010","article-title":"The dengue vaccine pipeline: Implications for the future of dengue control","volume":"33","author":"Schwartz","year":"2015","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/ijerph15020385","article-title":"Immune responses to dengue and Zika viruses-guidance for T cell vaccine development","volume":"15","author":"Roth","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw309","article-title":"HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-cell responses","volume":"214","author":"Weiskopf","year":"2016","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir012","article-title":"Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection","volume":"203","author":"Hatch","year":"2011","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.antiviral.2008.06.010","article-title":"Mouse models of dengue virus infection and disease","volume":"80","author":"Yauch","year":"2008","journal-title":"Antiviral Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/v4010062","article-title":"Animal models of dengue virus infection","volume":"4","author":"Zompi","year":"2012","journal-title":"Viruses"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00151","article-title":"Mouse models to study dengue virus immunology and pathogenesis","volume":"5","author":"Zellweger","year":"2014","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8727-1_16","article-title":"Animal models for dengue and Zika vaccine development","volume":"1062","author":"Alves Dos Santos","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003723","article-title":"Role of humoral versus cellular responses induced by a protective dengue vaccine candidate","volume":"9","author":"Zellweger","year":"2013","journal-title":"PloS Pathog"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00036-15","article-title":"CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice","volume":"89","author":"Zellweger","year":"2015","journal-title":"J Virol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.006","article-title":"Protective role of cross-reactive CD8 T cells against dengue virus infection","volume":"13","author":"Elong Ngono","year":"2016","journal-title":"EBioMedicine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01108-14","article-title":"Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection","volume":"88","author":"Weiskopf","year":"2014","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01309","article-title":"Global assessment of dengue virus-specific CD4(+) T cell responses in dengue-endemic areas","volume":"8","author":"Grifoni","year":"2017","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101970","article-title":"Insights into HLA-Restricted T Cell Responses in a Novel Mouse Model of Dengue Virus Infection Point toward New Implications for Vaccine Design","volume":"187","author":"Weiskopf","year":"2011","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01316\"10.3389\/fimmu.2019.01316","article-title":"Cross-reactive T cell immunity to dengue and Zika viruses: New insights into vaccine development","volume":"10","author":"Elong Ngono","year":"2019","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01778","article-title":"Assessing the diversity and stability of cellular immunity generated in response to the candidate live-attenuated dengue virus vaccine TAK-003","volume":"10","author":"Waickman","year":"2019","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1086\/519170","article-title":"Maternal antibody and viral factors in the pathogenesis of dengue virus in infants","volume":"196","author":"Simmons","year":"2007","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94500","article-title":"Dengue vaccine-induced cd8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies","volume":"2","author":"Lam","year":"2017","journal-title":"JCI Insight"},{"key":"B34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/519170","article-title":"Lentiviral vectors as a vaccine platform against infectious diseases","volume":"15","author":"Nemirov","year":"2023","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.05.016","article-title":"A single dose of nilv-based vaccine provides rapid and durable protection against zika virus","volume":"28","author":"Ku","year":"2020","journal-title":"Mol Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.12.010","article-title":"Intranasal vaccination with a lentiviral vector protects against sars-Cov-2 in preclinical animal models","volume":"29","author":"Ku","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111142","article-title":"A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4(+) T cell immunity","volume":"40","author":"Lopez","year":"2022","journal-title":"Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinf (Oxford England)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msw054","article-title":"Mega7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbx108","article-title":"MAFFT online service: Multiple sequence alignment, interactive sequence choice and visualization","volume":"20","author":"Katoh","year":"2017","journal-title":"Briefings Bioinf"},{"key":"B42","article-title":"Bioedit: A user-friendly biological sequence alignment editor and analysis program for windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp Ser"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-4528-2","article-title":"Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding","volume":"62","author":"Tenzer","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.4.1741","article-title":"Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors","volume":"171","author":"Peters","year":"2003","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-010-0441-4","article-title":"NetCTLpan: pan-specific MHC class I pathway epitope predictions","volume":"62","author":"Stranzl","year":"2010","journal-title":"Immunogenetics"},{"key":"B47","unstructured":"Los Alamos Hiv Database2018"},{"key":"B48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s42003-021-02251-6","article-title":"Lentiviral vector induces high-quality memory T cells via dendritic cells transduction","volume":"4","author":"Ku","year":"2021","journal-title":"Commun Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80828-4","article-title":"HIV-1 genome nuclear import is mediated by a central DNA flap","volume":"101","author":"Zennou","year":"2000","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01034-19","article-title":"Genetic diversity of collaborative cross mice controls viral replication, clinical severity, and brain pathology induced by Zika virus infection, independently of Oas1b","volume":"94","author":"Manet","year":"2020","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-6-10","article-title":"Development of real time PCR for detection and quantitation of dengue viruses","volume":"6","author":"Gurukumar","year":"2009","journal-title":"Virol J"},{"key":"B53","volume-title":"GraphPad Software. version 9.5.0 for Windows ed","year":"2022"},{"key":"B54","unstructured":"2018"},{"key":"B55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13073-015-0245-0","article-title":"Immunoinformatics and epitope prediction in the age of genomic medicine","volume":"7","author":"Backert","year":"2015","journal-title":"Genome Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1988854","article-title":"Use of lentiviral vectors in vaccination","volume":"20","author":"Ku","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114459","article-title":"Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice","volume":"13","author":"Ku","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2006.00395.x","article-title":"Functional signatures of protective antiviral T-cell immunity in human virus infections","volume":"211","author":"Harari","year":"2006","journal-title":"Immunol Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2020.12.011","article-title":"Dengue vaccines: The promise and pitfalls of antibody-mediated protection","volume":"29","author":"Martinez","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"a028811","DOI":"10.1101\/cshperspect.a028811","article-title":"Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? The risks of incomplete immunity to dengue virus revealed by vaccination","volume":"10","author":"Whitehead","year":"2018","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/vaccines8010063","article-title":"A review on dengue vaccine development","volume":"8","author":"Deng","year":"2020","journal-title":"Vaccines"},{"key":"B63","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/vaccines9060622","article-title":"Flavivirus NS1 and its potential in vaccine development","volume":"9","author":"Carpio","year":"2021","journal-title":"Vaccines"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: The multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis","volume":"5","author":"Glasner","year":"2018","journal-title":"Annu Rev Virol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jfma.2012.11.006","article-title":"Autoimmunity in dengue pathogenesis","volume":"112","author":"Wan","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00611-08","article-title":"A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads","volume":"82","author":"Prestwood","year":"2008","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00566-z","article-title":"A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity","volume":"15","author":"Anna","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/s41467-017-01728-5","article-title":"Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA","volume":"8","author":"Tian","year":"2017","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/v14020242","article-title":"Current understanding of the role of T cells in Chikungunya, Dengue and Zika infections","volume":"14","author":"Mapalagamage","year":"2022","journal-title":"Viruses"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01424","article-title":"A modified mRNA vaccine targeting immunodominant NS epitopes protects against dengue virus infection in HLA class I transgenic mice","volume":"10","author":"Roth","year":"2019","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600927","article-title":"A tetravalent formulation based on recombinant nucleocapsid-like particles from dengue viruses induces a functional immune response in mice and monkeys","volume":"197","author":"Gil","year":"2016","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2020.09.001","article-title":"Dengue mouse models for evaluating pathogenesis and countermeasures","volume":"43","author":"Chen","year":"2020","journal-title":"Curr Opin Virol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12977-017-0358-1","article-title":"Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells","volume":"14","author":"Geis","year":"2017","journal-title":"Retrovirology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/mthe.2002.0630","article-title":"Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow","volume":"6","author":"Pan","year":"2002","journal-title":"Mol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1208041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:34:44Z","timestamp":1692246884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1208041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2023.1208041"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1208041","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"1208041"}}